Ángel José Santos Iglesias

Biocross SL designs and develops diagnostic products for neurodegenerative diseases. Its products include multiparametric blood tests and biomarkers for identifying amytrophic lateral sclerosis, Parkinson's disease, and Alheimer's. The company was founded on January 26, 2005 and is headquartered in Boecillo, Spain.

One Way Liver SL designs and develops diagnostic solutions for liver conditions. It designs and develops of non-invasive diagnostic solutions for hepatic conditions, such as fatty liver disease and non-alcoholic steatohepatitis. The firm also provides research and clinical testing services to clients in the pharmaceutical and biomedical product industries. The company was founded by José Maria Mato de la Paz in 2002 and is headquartered in Derio, Spain.

Health in Code SL specializes in the genetic diagnosis of cardiovascular diseases. The firm provides gene panel testing and interpretation services for a variety of cardiopathies, including pulmonary hypertension, hypercholesterolemia and ventricular tachycardia. Its services include Medical Genetics, Laboratory Management System, HiC-Mutations and Laboratory Services. The company was founded by Lorenzo Jose Montserrat on June 23, 2006 and is headquartered in A Coruna, Spain.

Smart Solutions Technologies SL engages in the design, development, and manufacture of wireless medical devices. It offers fabric-integrated wearable electrocardiograph sensors and proprietary data management software platforms for monitoring physiological parameters, thereby aiding in prevention, diagnosis, and rehabilitation. The company was founded by Agustin Macia Barber, Luis Sanchez Morales, Rodrigo Miranda, and Jacobo Luis Crespo Criado del Rey on November 25, 2005, and is headquartered in Madrid, Spain.

Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain.

Iden Biotechnology SL provides biotechnological research and development services for agricultural applications. It offers applications in the production of high-yield, climate-resistant crops for food, energy, pharmaceuticals, and animal feeds. The firm also provides solutions for technology scouting, intellectual property brokering and licensing, research project management, and competitive intelligence. The company was founded by Nora Alonso on May 30, 2005 and is headquartered in Cordovilla, Spain.

Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain.